Φορτώνει......
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
As patents on many high-selling biological medicines are expiring, non-innovator versions, such as biosimilars, may enter this multi-billion dollar market. This study aims to map patents and patent applications for innovator as well as biosimilar monoclonal antibodies in Europe, and investigates leg...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Taylor & Francis Group
2020-01-01
|
Σειρά: | mAbs |
Θέματα: | |
Διαθέσιμο Online: | https://www.tandfonline.com/doi/10.1080/19420862.2020.1743517 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|